Roflumilast for COPD User Reviews (Page 3)
Brand names: Daliresp
Roflumilast has an average rating of 7.8 out of 10 from a total of 45 reviews for the treatment of COPD. 71% of reviewers reported a positive experience, while 13% reported a negative experience.
Reviews for Roflumilast
Reviews may be edited to correct grammar/spelling or to remove inappropriate language and content. Reviews that appear to be created by parties with a vested interest are not published. This information is not intended to endorse any particular medication. While these reviews may be helpful, they are not a substitute for the expertise, knowledge, and judgement of healthcare professionals.
Learn more about COPD
Care guides
- Acute Bronchitis
- Acute Bronchitis in Children
- Chronic Bronchitis
- Chronic Cough
- COPD (Chronic Obstructive Pulmonary Disease)
- Emphysema
Symptoms and treatments
Medicine.com guides (external)
More about roflumilast
- Check interactions
- Compare alternatives
- Reviews (69)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Drug class: selective phosphodiesterase-4 inhibitors
- Breastfeeding
- En español
"I have been on Roflumilast for four days and I can breathe easier again. It's a miracle pill for me."